ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
ALT-803（一种 IL-15 超激动剂）与 nivolumab 联合用于治疗转移性非小细胞肺癌患者：一项非随机、开放标签、1b 期试验
期刊:Lancet Oncology
影响因子:41.6
doi:10.1016/S1470-2045(18)30148-7
John M Wrangle, Vamsidhar Velcheti, Manish R Patel, Elizabeth Garrett-Mayer, Elizabeth G Hill, James G Ravenel, Jeffrey S Miller, Mohammad Farhad, Kate Anderton, Kathryn Lindsey, Michele Taffaro-Neskey, Carol Sherman, Samantha Suriano, Marzena Swiderska-Syn, Amy Sion, Joni Harris, Andie R Edwards, J
